164 related articles for article (PubMed ID: 37342330)
1. Case Report: Morbihan disease treated with tofacitinib successfully.
Li ZY; Chi CC; Cai SQ
Front Immunol; 2023; 14():1177316. PubMed ID: 37342330
[TBL] [Abstract][Full Text] [Related]
2. Tofacitinib Treatment of Refractory Cutaneous Leukocytoclastic Vasculitis: A Case Report.
Zhu KJ; Yang PD; Xu Q
Front Immunol; 2021; 12():695768. PubMed ID: 34248994
[TBL] [Abstract][Full Text] [Related]
3. Morbihan Disease - An Old and Rare Entity Still Difficult to Treat.
Jerković Gulin S; Ljubojević Hadžavdić S
Acta Dermatovenerol Croat; 2020 Aug; 28(2):118-119. PubMed ID: 32876040
[TBL] [Abstract][Full Text] [Related]
4. Morbihan disease misdiagnosed as senile blepharoptosis and successfully treated with short-term minocycline and ketotifen: A case report.
Na J; Wu Y
World J Clin Cases; 2023 Jul; 11(19):4692-4697. PubMed ID: 37469741
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of Morbihan disease with total glucosides of paeony: A case report.
Zhou LF; Lu R
World J Clin Cases; 2022 Jul; 10(19):6688-6694. PubMed ID: 35979289
[TBL] [Abstract][Full Text] [Related]
6. Oral Janus kinase inhibitors for maintenance of remission in ulcerative colitis.
Davies SC; Hussein IM; Nguyen TM; Parker CE; Khanna R; Jairath V
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012381. PubMed ID: 31984480
[TBL] [Abstract][Full Text] [Related]
7. Surgical Lymphoedema Treatment of Morbihan Disease: A Case Report.
Hattori Y; Hino H; Niu A
Ann Plast Surg; 2021 May; 86(5):547-550. PubMed ID: 33661216
[TBL] [Abstract][Full Text] [Related]
8. Morbihan disease.
Hu SW; Robinson M; Meehan SA; Cohen DE
Dermatol Online J; 2012 Dec; 18(12):27. PubMed ID: 23286817
[TBL] [Abstract][Full Text] [Related]
9. Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty-Four-Month, Phase III Study.
van der Heijde D; Strand V; Tanaka Y; Keystone E; Kremer J; Zerbini CAF; Cardiel MH; Cohen S; Nash P; Song YW; Tegzová D; Gruben D; Wallenstein G; Connell CA; Fleischmann R;
Arthritis Rheumatol; 2019 Jun; 71(6):878-891. PubMed ID: 30666826
[TBL] [Abstract][Full Text] [Related]
10. Morbihan Disease: A Rare Case of Periorbital Bilateral Edema with Histopathological Findings of Chronic Inflammation and Demodex Localization.
Di Maria A; Confalonieri F; Barone G; Manara S; Ferraro V
Am J Case Rep; 2024 Jun; 25():e943421. PubMed ID: 38872283
[TBL] [Abstract][Full Text] [Related]
11. Morbihan disease: a case report and differentiation from Melkersson-Rosenthal syndrome.
Kuraitis D; Coscarart A; Williams L; Wang A
Dermatol Online J; 2020 Jun; 26(6):. PubMed ID: 32815689
[TBL] [Abstract][Full Text] [Related]
12. Folliculotropic Cutaneous Metastases and Lymphangitis Carcinomatosa: When Cutaneous Metastases of Breast Carcinoma Are Mistaken for Cutaneous Infections.
Paolino G; Panetta C; Didona D; Donati M; Donati P
Acta Dermatovenerol Croat; 2016 Jun; 24(2):154-7. PubMed ID: 27477179
[TBL] [Abstract][Full Text] [Related]
13. Tofacitinib, an oral Janus kinase inhibitor, in patients from Mexico with rheumatoid arthritis: Pooled efficacy and safety analyses from Phase 3 and LTE studies.
Burgos-Vargas R; Cardiel M; Xibillé D; Pacheco-Tena C; Pascual-Ramos V; Abud-Mendoza C; Mahgoub E; Rahman M; Fan H; Rojo R; García E; Santana K
Reumatol Clin (Engl Ed); 2019; 15(1):43-53. PubMed ID: 28552437
[TBL] [Abstract][Full Text] [Related]
14. Tofacitinib, an oral Janus kinase inhibitor, for the treatment of Latin American patients with rheumatoid arthritis: Pooled efficacy and safety analyses of Phase 3 and long-term extension studies.
Radominski SC; Cardiel MH; Citera G; Goecke A; Jaller JJ; Lomonte ABV; Miranda P; Velez P; Xibillé D; Kwok K; Rojo R; García EG
Reumatol Clin; 2017; 13(4):201-209. PubMed ID: 27317492
[TBL] [Abstract][Full Text] [Related]
15. Bullous Pemphigoid Masquerading as Erythema Annulare Centrifugum.
Yu-Yang S; Chu-Sung Hu S; Yiao-Lin S
Acta Dermatovenerol Croat; 2017 Oct; 25(3):255-256. PubMed ID: 29252183
[TBL] [Abstract][Full Text] [Related]
16. Maintenance of Remission With Tofacitinib Therapy in Patients With Ulcerative Colitis.
Colombel JF; Osterman MT; Thorpe AJ; Salese L; Nduaka CI; Zhang H; Lawendy N; Friedman GS; Quirk D; Su C; Reinisch W
Clin Gastroenterol Hepatol; 2022 Jan; 20(1):116-125.e5. PubMed ID: 33039585
[TBL] [Abstract][Full Text] [Related]
17. Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib.
Chen YL; Liu LX; Huang Q; Li XY; Hong XP; Liu DZ
Front Immunol; 2021; 12():654376. PubMed ID: 33936080
[TBL] [Abstract][Full Text] [Related]
18. Tofacitinib in the treatment of Indian patients with rheumatoid arthritis: A post hoc analysis of efficacy and safety in Phase 3 and long-term extension studies over 7 years.
Chopra A; Shobha V; Chandrashekara S; Veeravalli SCM; Sharma R; Rao UR; Pandya S; Wagh S; Kadel JK; Thorat AV; Adhav C; Santos Estrella P; Yu W; Kwok K; Wouters A
Int J Rheum Dis; 2020 Jul; 23(7):882-897. PubMed ID: 32478474
[TBL] [Abstract][Full Text] [Related]
19. Successful management with Janus kinase inhibitor tofacitinib in refractory juvenile dermatomyositis: a pilot study and literature review.
Yu Z; Wang L; Quan M; Zhang T; Song H
Rheumatology (Oxford); 2021 Apr; 60(4):1700-1707. PubMed ID: 33024992
[TBL] [Abstract][Full Text] [Related]
20. Tofacitinib Suppresses Several JAK-STAT Pathways in Rheumatoid Arthritis
Palmroth M; Kuuliala K; Peltomaa R; Virtanen A; Kuuliala A; Kurttila A; Kinnunen A; Leirisalo-Repo M; Silvennoinen O; Isomäki P
Front Immunol; 2021; 12():738481. PubMed ID: 34630419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
